21%. No preoperative clinical or morphologic or procedural data were correlated with SIL. Pancreatic, hepatic, or renal function worsening occurred at 24 hours in 16 (44%), 16 (44%), and 8 (22%) cases, respectively. Overall, SILs were associated with increased values of C-reactive protein (17.9 6 0.4 vs 9.9 6 9.0 mg/dL; P ¼ .03) and bilirubin (1.2 6 2.3 vs 1.0 6 0.5 mg/dL; P ¼ .02) at 24 hours. Specifically, SILs of the celiac trunk, superior mesenteric, and renal arteries' parenchyma were associated with significant laboratory function changes at 24 hours summarized in the Table. SIL of the superior mesenteric artery was associated with increased 30-day mortality (50% vs 7 %; P ¼ .002). Pancreatic, hepatic, or renal function worsening occurred at 30-day in 2 (6%), 0 (0%), and 4 (12%) cases, with similar laboratory tests in patients with and without SIL.
IP069.

Suppression of the Hospitalization Length and Costs During Open Repair for Abdominal Aortic Aneurysm Is Achieved by High Quality Surgery and Enhanced Recovery Program Rather Than Patients' Background
Takuro Shirasu, Takatoshi Furuya, Yukihiro Nomura. Asahi General Hospital, Chiba, Japan
Objectives: The goal of this study was to determine the factors to increase the hospitalization length and costs of open repair (OR) for abdominal aortic aneurysm (AAA).
Methods: This was a retrospective study of a prospectively accumulated database at Asahi General Hospital between 1998 and 2015. A total of 579 consecutive patients who underwent open repair for intact AAA and survived were included in the analysis. Patients' characteristics, operation outcomes and postoperative courses were analyzed in relation to the hospitalization costs. Patients with higher costs group (more than third quartile range) were compared with patients with lower costs group. . Embolic complications occurred in 33 patients (6%) and redo surgery in 18 patients (3%). Median days (interquartile range) to first ambulation and resumption of normal diet were 1 (1-2) and 4 (3-4). A total of 595 patients (98.0%) were discharged home. Median hospital length of stay was 7 (7-8) days. Median of total hospitalization costs were 1,230,000 (1,180,000-1,310,000) Japanese Yen. After excluding confounding factors by the analysis of correlation coefficient and stepwise regression method, transfusion (hazard ratio [HR], 5.1), time to first ambulation >2 days (HR, 5.7) and postoperative fasting time >5 days (HR, 14.1) were significantly related to longer hospitalization (>9 days) in the multivariate analysis. As to the higher hospitalization costs (>1,310,000 Japanese Yen), the multivariate analysis revealed male sex (HR, 2.3), diameter >6 cm (HR, 2.1), operation time > 210 minutes (HR, 3.1), transfusion (HR, 44.2), redo surgery (HR, 15.4), and postoperative fasting time >5 days (HR, 4.6) were significant risk factors.
Conclusions: High-quality operations with short time and avoidance of transfusion and redo surgery, combined with early ambulation and enteral feeding, can reduce the total hospitalization costs.
Author Disclosures: T. Furuya: Nothing to disclose; Y. Nomura: Nothing to disclose; T. Shirasu: Nothing to disclose.
IP071. Persistent Type II Endoleak Prevention by Abdominal Aortic Aneurysm Sac Embolization During EVAR: An Analysis of Aneurysm Volume and Coils Concentration
Chiara Mascoli, Mauro Gargiulo, Enrico Gallitto, Matteo Longhi, Rodolfo Pini, Stefano Ancetti, Gianluca Faggioli, Andrea Stella. University of Bologna, Bologna, Italy Objectives: Intraoperative abdominal aortic aneurysm (AAA) sac embolization in selected high-risk patients during endovascular aortic repair (EVAR) is effective to reduce persistent type II endoleaks (ELIIp) incidence. The method to obtain a complete sac thrombosis has not been standardized yet. Aim of our study was to identify predictors of ELIIp prevention after intraoperative embolization in order to define the details of the technique.
Methods: Patients at high risk for ELIIp (pretreatment presence of $6 efferent patent vessels from AAA sac and/or AAA thrombus volume ratio [VR%] <40%) who underwent EVAR and intraprocedural AAA sac coil embolization between 2012 and 2015 were prospectively collected. The endoluminal AAA free thrombus sac volume (EFV), not occupied by the endograft (EFV ¼ AAA total volume [TV] e (AAAthrombus volume [THV] + endograft volume [EgV]) was retrospectively identified on the preoperative computed tomography, and the concentration of coils implanted (CCoil ¼ number coils implanted/EFV) for each patient was evaluated. ELIIp presence was evaluated by contrast-enhanced ultrasound imaging at 6 and 12 months. Patients with ELIIp at 12 months (group 1) were clustered and compared to patients without ELIIp (group 2) in order to evaluate the incidence of ELIIp in patients who underwent preventive AAA sac embolization and identify the predictors of ELIIp prevention. Morphological potential risk factors for ELIIp, such as TV, THV, VR%, and EgV, were also considered.
Results: Among 326 patients undergoing EVAR, coil embolization was performed in 61 (19%; males: 96.7%, age: 72.2 6 8 years, mean AAA diameter: 57 6 7 mm). The mean AAA TV and mean EFV were 156 6 60 mL and 46 6 25 mL, respectively. The median number and mean concentration of coils Cook M-Ray) were 4.5 6 1.4 and 0.17 coil/cc (range, 0.02-1.20). Incidence of ELIIp was 29.5% at 6 months and 23% at 12 months, respectively. Fourteen aPTT, Activated partial thromboplastin time.
